Browsing Tag
Cathal Friel
2 posts
European Green Transition (AIM: EGT) revenue jump validates wind pivot
European Green Transition’s first post-acquisition trading period points to strong wind-services demand, but converting a £126 million repowering pipeline will determine whether its £50 million revenue ambition is realistic.
Poolbeg Pharma (AIM: POLB) raises £3.5m to fund POLB 001 and oral GLP-1 trials
The discounted placing should fund two potentially value-defining clinical studies through completion, although investors must absorb a larger share base before either programme produces proof-of-concept data.